Search

Your search keyword '"Gillard JW"' showing total 31 results

Search Constraints

Start Over You searched for: Author "Gillard JW" Remove constraint Author: "Gillard JW"
31 results on '"Gillard JW"'

Search Results

2. Alkaloids of Darlingia ferruginea

Catalog

Books, media, physical & digital resources

3. Alkaloids of Darlingia darlingiana

4. Alkaloids of Bellendena montana

7. Effects of Two Soluble ACE2-Fc Variants on Blood Pressure and Albuminuria in Hypertensive Mice: Research Letter.

8. Inhibition of carbonic anhydrase IX in glioblastoma multiforme.

9. Reliability and minimal detectable change of physical performance measures in individuals with pre-manifest and manifest Huntington disease.

10. Cytoprotective effects of IAPs revealed by a small molecule antagonist.

11. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination.

12. X-linked inhibitor of apoptosis regulates T cell effector function.

13. Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis.

14. AEG3482 is an antiapoptotic compound that inhibits Jun kinase activity and cell death through induced expression of heat shock protein 70.

15. Application of XIAP antisense to cancer and other proliferative disorders: development of AEG35156/ GEM640.

16. Naphthalenic lignan lactones as selective, nonredox 5-lipoxygenase inhibitors. Synthesis and biological activity of (methoxyalkyl)thiazole and methoxytetrahydropyran hybrids.

17. Discovery of inhibitors of the 5-lipoxygenase activating protein (flap).

18. Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)- indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor.

19. Characterization of a 5-lipoxygenase-activating protein binding assay: correlation of affinity for 5-lipoxygenase-activating protein with leukotriene synthesis inhibition.

20. 5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors.

21. Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis.

22. MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes.

23. Identification and isolation of a membrane protein necessary for leukotriene production.

24. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis.

25. Adriamycin analogues. Novel anomeric ribofuranoside analogues of daunorubicin.

27. Tetrahydrocarbazol-1-acetic acids: new class of thromboxane receptor antagonists.

28. Metabolic synthesis of arylacetic acid antiinflammatory drugs from arylhexenoic acids. 2. Indomethacin.

29. The use of synthetic thromboxane A2 (TXA2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor.

30. Biogenesis of proteaceous alkaloids.

31. Photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 receptor.